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Background
Induction of oral tolerance (IOT) represents a new
treatment for cow´s milk proteins (CMP) allergy. Several
studies show that it is safe and effective in most of
cases,but do we have controlled all the risks and
complications?
Methods
We evaluated 59 patients with IgE-mediated allergy for
CMP on whom we administered IOT treatment accord-
ing to our protocol. Initial induction phase was made at
hospital (up to 2.5ml), followed by a maintenance phase
at home, with an increase of the weekly dosage that was
performed in the outpatient clinic. Once a dose of
200ml/day was achieved, continued daily dose was taken
at home. We did a clinical follow-up at 6 months and
then annually, with skin prick tests and specific IgE
levels. We pay special attention to the problems and
complications that arose during the IOT and its subse-
quent follow-up.
Results
We completed IOT in 58 of 59 patients. Initial IgE spe-
cific value for casein was 10.7 KU/L (median). Duration
of IOT: 117±47 days (mean). 39% had reactions during
induction phase, 47.5% in weekly hospital visit and
83.1% at home (but only 10% were severe). 43 patients
were followed for at least one year, 20.3% of them had
adverse reactions (most mild reactions). One patient had
anaphylaxis after ingesting ibuprofen with cow’s milk.
Another patient is taking omalizumab for severe asthma.
4 (9% of total) presented digestive symptoms and were
subsequently diagnosed of eosinophilic esophagitis. All
patientsfeel they have improved their quality of life and
no one of them is willing to stop eating CMP despite
adverse effects described and even 2 patients began after
one year, IOT for egg protein. There was asignificant
decrease in specific IgE levels and prick test values one
year later of CMP IOT.
Conclusion
IOT is a safe treatment for CMP allergy with very good
results. However, we do not know the outcomes of
these patients in the long term and we need close moni-
toring to prevent adverse events or treat if necessary.
Even so, patients generally want to keep taking cow´s
milk due to the benefits obtained in their quality of life.
Disclosure of interest
None declared.
Published: 25 July 2013
doi:10.1186/2045-7022-3-S3-P17
Cite this article as: Muñoz Archidona et al.: Induction of oral tolerance
for cow’s milk proteins. Is everything under control? Clinical and
Translational Allergy 2013 3(Suppl 3):P17.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Pediatrics, Hospital Severo Ochoa, Leganés, Madrid, Spain
Muñoz Archidona et al. Clinical and Translational Allergy 2013, 3(Suppl 3):P17
http://www.ctajournal.com/content/3/S3/P17
© 2013 Muñoz Archidona et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
